Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
about
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
@en
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
@nl
type
label
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
@en
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
@nl
prefLabel
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
@en
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
@nl
P2860
P1476
Health policy: Me-too drugs with limited benefits - the tale of regorafenib for HCC.
@en
P2093
Vinay Prasad
P2860
P304
P356
10.1038/NRCLINONC.2017.100
P407
P577
2017-07-18T00:00:00Z